Emilio José
Sanz Álvarez
Catedrático de Universidad
Centro de Investigacion Biomedica en Red de Salud Mental
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigacion Biomedica en Red de Salud Mental (10)
2024
-
Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)
Schizophrenia Research, Vol. 268, pp. 165-174
-
An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance
Schizophrenia Research, Vol. 268, pp. 53-59
-
An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance
Schizophrenia Research, Vol. 268, pp. 60-65
-
Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature
Expert Opinion on Drug Safety
-
Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database
Schizophrenia Research, Vol. 268, pp. 118-130
-
Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia
Expert Opinion on Drug Metabolism and Toxicology, Vol. 20, Núm. 8, pp. 857-871
-
Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
Schizophrenia Research, Vol. 268, pp. 175-188
2023
-
Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom
Journal of Clinical Psychopharmacology, Vol. 43, Núm. 3, pp. 239-245
-
Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase
Expert Opinion on Drug Metabolism and Toxicology, Vol. 19, Núm. 2, pp. 57-74
2022
-
Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review
Expert Opinion on Drug Metabolism and Toxicology, Vol. 18, Núm. 11, pp. 715-727